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Objective: To determine whether hip abductor and adductor muscle strengthening reduces medial
compartment knee load and improves symptoms in people with medial tibiofemoral OA and varus
malalignment.
Methods: In a randomised controlled trial, 89 participants were randomly allocated to a hip strengthening
group or to a control group with no intervention. The strengthening group performed a physiotherapist-
supervised home exercise program targeting the hip abductor and adductor muscles for 12 weeks. The
primary outcome was the peak external knee adduction moment measured using three-dimensional gait
analysis by a blinded assessor. Secondary outcomes included a pain numeric rating scale, Western Ontario
and McMaster Universities Osteoarthritis Index, step test, stair climb test, maximum isometric strength of
hip and quadriceps muscles and participant-perceived rating of overall change. Intention-to-treat
analyses were performed using linear regression modelling adjusting for baseline outcomes and other
characteristics.
Results: The trial was completed by 76/89 participants (85%). There was no signiﬁcant between-group
difference in change in the knee adduction moment [mean difference (95% conﬁdence interval (CI)) 0.134
(0.069 to 0.337) Nm/BWHT%]. All pain, physical function and muscle strength measures showed
signiﬁcantly greater improvement in the strengthening group (all P< 0.05). The relative risk (95% CI) of
participant-perceived overall improvement in the strengthening group compared to the control group
was 20.02 (6.21e64.47).
Conclusions: Although strengthening the hipmuscles improved symptoms and function in this patient group,
it did not affect medial knee load as measured by the knee adduction moment. Thus it is unlikely that hip
muscle strengthening inﬂuences structural disease progression. Trial registration: ACTR12607000001493.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Knee osteoarthritis (OA) occurs predominantly in the medial
tibiofemoral compartment1,2 and those with varus knee malalign-
ment are particularly at risk of disease progression3. As there is
no cure, management for knee OA has targeted symptoms and
clinical guidelines reinforce the importance of conservative,: Kim L. Bennell, School of
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s Research Society International. Pnon-pharmacologic treatments4,5. However, there is increasing
interest in identifying treatments that may also slow disease
progression. Given that increased knee joint load is strongly
implicated in structural deterioration6, interventions with the
potential to both improve symptoms and reduce knee load are
worthy of investigation.
As in vivo measurement of knee load is difﬁcult, the external
knee adduction moment obtained from three-dimensional gait
analysis provides a valid and reliable indirect measure of load in the
medial tibiofemoral compartment7e9. Studies show that patients
with knee OA, particularly those with varus malalignment, have
a higher peak knee adduction moment when compared to healthy
age-matched controls10,11. The magnitude of the adduction
moment is also predictive of clinical outcomes in knee OA, such as
severity of knee pain12 and radiographic evidence of disease13.
Importantly, longitudinal data show that as little as a one-unitublished by Elsevier Ltd. All rights reserved.
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6.5-fold increase in the risk of disease progression6. Given the
signiﬁcance of the knee adduction moment with regard to both
symptom severity and disease progression in knee OA, conservative
strategies to reduce the knee adduction moment constitute
a logical rehabilitative approach.
Exercise is recommended for knee OA14,15 and quadriceps
strengthening forms the cornerstone of exercise therapy16.
Although numerous studies demonstrate the symptomatic beneﬁts
of quadriceps strengthening17e19, we have recently shown that
quadriceps strengthening does not inﬂuence the knee adduction
moment (KAM) in medial knee OA20. Furthermore, the only clinical
trial evaluating the effect of quadriceps strengthening on structural
progression failed to ﬁnd a signiﬁcant effect21. Taken together, these
ﬁndings indicate that the role of isolated quadriceps strengthening
in the protection against disease progression may be limited.
Muscle weakness in knee OA is not just conﬁned to the quad-
riceps. Other lower limb muscles including the hip abductors and
adductors are also weaker (Hinman et al., unpublished data) and
emerging data suggest that thesemusclesmay play a role in disease
pathogenesis. Recent evidence implies that hip abductor and
adductor muscle strength may be important for reducing the knee
adduction moment22 and a longitudinal cohort study found that
people with a lower external hip adduction moment (possibly from
weaker hip abductor muscles) demonstrated more rapid knee OA
progression23. The exact mechanism by which hip abductor and
adductor muscles may inﬂuence medial knee loading is unclear.
However, their role has been implicated in stabilising the pelvis and
trunk in the frontal plane22e25 and in eccentric control of frontal
plane femoral angles26. Thus, hip muscle function appears to be an
important, yet under-investigated, contributor to medial knee joint
load and has clinical relevance for load-modifying interventions.
The primary aim of this trial was to determine whether
strengthening the hip abductor and adductor muscles in people
with medial tibiofemoral OA and varus malalignment reduces
medial knee joint loading as quantiﬁed by the peak external knee
adduction moment. The secondary aimwas to assess whether a hip
strengthening program reduces knee pain and improves physical
function.
Methods
Participants
Participants aged over 50 years were recruited from the
community through advertisements in newspapers and local clubs
and from our database of research volunteers. All had OA in at least
one knee fulﬁlling the American College of Rheumatology classiﬁ-
cation criteria27 and reported average knee pain on walking >3 on
an 11-point scale (0¼ no pain; 10¼maximal pain). To ensure
medial tibiofemoral OA and varus malalignment, inclusion criteria
were medial knee pain and medial compartment osteophytes or
medial joint space narrowing28 and knee alignment 182 on
a standardised semiﬂexed posteroanterior X-ray (corresponding to
a mechanical axis of 180)29. Exclusion criteria were no or
doubtful radiographic OA [Kellgren and Lawrence (KL) grades 0 and
130], knee surgery or intra-articular corticosteroid injection within
6 months, current or past (within 4 weeks) oral corticosteroid use,
systemic inﬂammatory arthritic conditions, a history of hip or knee
joint replacement or tibial osteotomy, intention to start or currently
participating in a supervised lower limb strengthening program,
body mass index> 35 due to difﬁculty in accurate marker place-
ment for gait analysis, a medical condition that precluded safe
participation in an exercise program or unable to ambulate without
a gait aid.The trial was performed in compliance with the Helsinki
declaration. Ethical approval was obtained from the University of
Melbourne Human Research Ethics Committee (HREC no.
0709220). All participants provided written informed consent.
Procedures
We conducted a 12-week, randomised, assessor-blinded
controlled trial (Fig.1). Detailed description of themethodology has
been published previously31. Potential participants underwent
telephone screening, standardised weight bearing X-ray and clin-
ical examination by a physiotherapist to determine eligibility. To
include a range of radiographic disease severity, we limited
recruitment of participants for each grade of OA severity to 30 (KL
grades 2, 3, and 4)30. Participants were stratiﬁed by radiographic
disease severity and randomly allocated in permuted blocks of 4e6
to hip strengthening or control groups according to a computer-
generated table of random numbers created by an independent
investigator not directly involved in assessment of participants.
Allocation was sealed in opaque and consecutively numbered
envelopes held in a central location. These were opened in
sequence by a person not involved in the study after recruitment
and baseline testing of participants.
Interventions
All participants were asked to refrain from seeking other forms
of treatment during the trial. However, due to ethical consider-
ations, analgesia and non-steroidal anti-inﬂammatory drugs were
permitted as required.
Hip strengthening
Participants performed a standardised set of home exercises ﬁve
times per week for 12 weeks31. Six exercises to strengthen hip
abductor and adductor muscles were performed in side-lying and
standing (three sets of 10 repetitions) with ankle cuff weights or
elastic bands. Additionally, participants attended a physiotherapy
clinic on seven occasions (once weekly for the ﬁrst 5 weeks then
fortnightly) to receive appropriate instruction on exercises and safe
progression of resistance. These were individual sessions lasting
30 min initially and 15 min subsequently. The therapists, who had
15.6 (10.1) years of clinical experience and had all been involved in
previous research studies, were trained to deliver the exercises
prior to the study. They adjusted exercise intensity as determined
by the participant's ability to complete 10 repetitions for a given
exercise.
Control
Control group participants did not receive any additional
intervention or complete any home exercises during the 12 weeks.
Outcome assessment
Participants were assessed at baseline and at 13 weeks by an
assessor blinded to group allocation. Age, gender, duration of knee
OA symptoms, previous treatment, surgery and medication use for
knee OA were obtained at baseline.
Gait measures
Participants underwent three-dimensional gait analyses
walking barefoot at a self-selected normal pace along a 10 m
walkway with speed monitored by two photoelectric beams. The
same speed (5%) was used at follow-up. Kinematic data were
collected using a Vicon motion analysis systemwith eight M2/MX-
F20 CMOS cameras operating at 120 Hz (Vicon, Oxford, UK). The
Fig. 1. Trial protocol.
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were placed anteriorly at the sternal notch and posteriorly over the
spinous processes of T2 and T10 to construct a local segment
coordinate system ﬁxed to the thorax32 and enable calculation of
lateral trunk lean. Lastly, medial knee and ankle markers were
included during an initial static standing trial to determine relative
positioning of knee and ankle joint centres. Kinetic data were
collected using two, ﬂoor-mounted 0R6-6-2000 force platforms at
a sampling rate of 1080 Hz (Advanced Mechanical Technology Inc.,
Watertown, MA, USA), in synchrony with the cameras. Net external
joint moments were calculated via inverse dynamics (Vicon Plug-
In-Gait v2). Pain during gait analysis was assessed verbally using an
11-point numerical rating scale (0¼ no pain; 10¼maximum pain).
The primary outcome was the peak external KAM during stance
phase, normalised to body weight (BW) and height (Nm/BWHT
%). Our testeretest reliability for this measure is excellent [intra-
class correlation coefﬁcient (ICC3,5) of 0.97]. Other biomechanical
variables included the positive area under the KAM curve (knee
adduction impulse), peak external hip adduction moment during
stance, maximum contralateral pelvic drop, ipsilateral trunk lean in
the frontal plane, and foot toe-out angle. Five trials were obtained
for the test limb and all discrete data were averaged across trials.
Knee pain and physical function
Overall average knee pain and knee pain on walking in the past
week were assessed by 11-point horizontal numeric rating scales
with terminal descriptors of 0¼ no pain; 10¼maximal pain33. Self-
reported knee pain and difﬁculty with physical function were
measured using the Western Ontario and McMaster Universities
(WOMAC)OA Index34where higher scores indicateworse symptoms.
At study completion, participants rated their overall perceived
change (compared to baseline) on an ordinal scale (1 e much
worse, 2 e slightly worse, 3 e no change, 4 e slightly better, 5 e
much better)35. Improvement was deemed a priori as ‘slightly
better’ or ‘much better’.
Objective physical function tests included the step test and
a timed stair ascent/descent task. The step test is a functional,
dynamic test of standing balance36 whereby participants stand
barefoot on the study leg in front of a 15 cm step and step the
opposite foot on and off the step as quickly as possible over 15 s.
The number of times the foot can be placed up onto the step and
returned to the ﬂoor is recorded, with higher scores suggesting
better balance. The stair ascent/descent task involves the timedTable I
Baseline characteristics of total participants and of those who were lost to follow-up in
Characteristic Participants
Randomised (n¼ 89)
Exercise (n¼ 45)
Age (yr), mean (SD) 64.5 (9.1)
Gender, n males (%) 22 (48.9%)
Knee affected, n right (%) 27 (60.0%)
Symptoms, n unilateral (%) 18 (40.0%)
Body mass index (kg/m2), mean (SD) 27.5 (4.7)
Static knee alignment (), mean (SD) 176.4 (2.6)
KL grade n (%)
Grade 2 15 (33.3%)
Grade 3 15 (33.3%)
Grade 4 15 (33.3%)
Physical activity levels, mean (SD)y 251.1 (88.1)
Current medication use n (%) 28 (62.2%)
Analgesics 7 (15.6%)
Non-steroidal anti-inﬂammatories 11 (24.4%)
Nutraceuticals (e.g., glucosamine) 17 (37.8%)
y Measured using the PASE from 0 to 400 with higher scores indicating higher activitascent and descent of six stairs, with longer times indicating poorer
physical function37.
Strength measures
Maximal isometric strength of hip abduction and hip adduction
were measured in supine while hip ﬂexion, internal rotation and
external rotation were measured in sitting using a handheld
dynamometer (Nicholas MMT, Lafayette Instruments, Lafayette, IN,
USA)38. Hip extension strength was measured in supine using
a force transducer38. Isometric quadriceps muscle strength at 60 of
knee ﬂexion was assessed in sitting using the Kin-Com 125-AP
dynamometer (Chattecx Corporation, Chattanooga, TN, USA)20.
After a single, submaximal trial, participants performed three
trials each of 5 s duration, separated by 15 s of rest. The maximum
force output (N) from the three trials (corrected for gravitational
weight of the limb as appropriate) was recorded and converted to
torque (Nm) by multiplying by the resistance lever arm (m), then
normalised to body mass (Nm/kg). These strength tests have
excellent testeretest reliability in our laboratory (ICCs¼ 0.84e0.98).
Other measures
Physical activity was measured using the physical activity scale
for the elderly (PASE) which assesses the level and type of recrea-
tional and occupational physical activities undertaken by partici-
pants over the previous week39.
Co-interventions, medication use and adverse events were
recorded by participants in a weekly logbook. Adherence in the
strengthening group was assessed as the number of physiotherapy
sessions attended (maximum of seven converted to a percentage)
and the number of home exercise sessions performed (maximum of
60 exercise days converted to a percentage).
Sample size calculations
We estimated an achievable and clinically relevant change in the
peak knee adduction moment as being 7.5% because this may be
associated with an approximate 2-fold reduction in the risk of
structural disease progression6,40 and because other non-pharma-
cological conservative interventions such as lateral wedge insoles
can achieve reductions of this magnitude6,40. Based on our previous
studies, a 7.5% reduction equates to an absolute change of
approximately 0.3 Nm/BWHT%20,40. Estimates of the standard
deviation of change are 0.4 Nm/BWHT% based on our data andboth groups
Lost to follow-up (n¼ 13)
Control (n¼ 44) Exercise (n¼ 6) Control (n¼ 7)
64.6 (7.6) 62.7 (10.3) 62.7 (8.2)
24 (54.5%) 2 (33.3%) 3 (42.9%)
21 (47.7%) 3 (50.0%) 3 (42.9%)
15 (34.1%) 1 (16.7%) 2 (28.6%)
28.4 (4.1) 28.7 (4.0) 30.2 (3.7)
177.2 (2.3) 175.3 (4.7) 177.6 (2.1)
15 (34.1%) 1 (16.7%) 3 (42.9%)
14 (31.8%) 2 (33.3%) 0 (0%)
15 (34.1%) 3 (50.0%) 4 (57.1%)
237.6 (81.0) 211.6 (91.1) 240.7 (56.7)
33 (75.0%) 4 (66.7%) 6 (85.7%)
14 (31.8%) 0 (0.0%) 2 (28.6%)
11 (25.0%) 2 (33.3%) 3 (42.9%)
20 (45.5%) 3 (50.0%) 2 (28.6%)
y levels.
Table II
Mean (SD) of groups, mean (SE) difference within groups, and mean (95% CI) difference between groups for the primary outcome and other biomechanical variables
Groups, mean (SD) Difference within groups,
adjusted mean (SE)y
Difference between groups,
adjusted mean (95% CI)
Week 0 Week 13 Week 13eWeek 0 Week 13eWeek 0
Exercise Control Exercise Control Exercise Control ExerciseeControl P-values
Peak knee adduction moment (Nm/BWHT%) 3.2 (1.0) 2.9 (0.9) 3.3 (0.9) 2.9 (0.9) 0.15 (0.07) 0.02 (0.07) 0.13 (0.07, 0.34) 0.193
Peak hip adduction moment (Nm/BWHT%) 5.3 (0.9) 5.1 (1.2) 5.4 (0.9) 5.2 (1.1) 0.12 (0.11) 0.04 (0.11) 0.08 (0.23, 0.39) 0.620
Knee adduction impulse 1.1 (0.4) 1.0 (0.4) 1.1 (0.4) 1.0 (0.4) 0.05 (0.03) 0.02 (0.03) 0.04 (0.05, 0.12) 0.407
Maximum contralateral pelvic drop (deg) 3.7 (2.6) 3.0 (2.2) 4.0 (2.5) 2.9 (2.0) 0.54 (0.21) 0.22 (0.21) 0.77 (0.15, 1.38) 0.015
Maximum ipsilateral trunk lean (deg) 3.3 (2.2) 4.0 (2.7) 2.7 (1.8) 3.7 (2.7) 0.74 (0.23) 0.20 (0.23) 0.54 (1.21, 0.14) 0.116
Toe-out in stance (deg) 6.0 (4.6) 7.3 (5.4) 5.6 (4.6) 5.9 (5.2) 0.37 (0.35) 1.38 (0.36) 1.01 (0.02, 2.03) 0.055
y Peak knee adduction moment adjusted for baseline value, KL grade, change in pain during gait testing and change in walking speed. Other biomechanical variables were
adjusted for baseline value, KL grade and change in pain during gait testing.
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detect a 0.3 Nm/BWHT% change with 90% power (alpha¼ 0.05).
We assumed an attrition rate of 15%, thus at least 44 participants
per group were required.
Statistical analysis
Analyses were performed blinded and using an intention-to-
treat principle. Missing data were replaced using the last observa-
tion carried forward. For continuous outcomes, differences in mean
change between groups were evaluated using linear regression
modelling with adjustment for baseline scores. For the knee
adduction moment, additional covariates included change in gait
speed, disease severity, and change in walking pain during testing.
For other biomechanical variables, additional covariates were
disease severity and change in walking pain during testing. These
covariates were chosen given some evidence of their association
with the knee adduction moment (e.g., Ref. 12). Model assumptions
were checked by standard diagnostic plots. Participant rating of
overall perceived change in pain and function was compared
between groups by calculating relative risks with 95% conﬁdence
intervals using log binomial regression.
Results
Eighty-nine participants were recruited (45 strengthening, 44
control) between October 2007eJanuary 2009 and 76 (39
strengthening, 37 control; 85%) completed the trial (Fig. 1).
Participant characteristics are shown in Table I, with groups similar
at baseline. Characteristics of participants lost to follow-up did not
differ to those completing the study (Table I). Assessor unblindingTable III
Mean (SD) of groups, mean (SE) difference within groups, and mean (95% CI) difference
Groups, mean (SD)
Week 0 Week 13
Exercise Control Exercise C
Pain on walking (0e10) 4.3 (2.0) 4.1 (2.5) 2.6 (2.1)
WOMAC function (0e68) 24.8 (10.9) 23.7 (11.8) 16.2 (11.7) 2
WOMAC pain (0e20) 7.7 (3.0) 6.9 (3.3) 4.9 (3.3)
Step test (n) 16.2 (3.7) 16 (2.9) 18 (4.3) 1
Timed stair task (s) 8.0 (2.7) 8.2 (2.3) 7.0 (2.2)
Knee extension torque (Nm/kg) 1.5 (0.5) 1.4 (0.6) 1.6 (0.4)
Hip ﬂexion torque (Nm/kg) 0.8 (0.2) 0.8 (0.2) 0.8 (0.2)
Hip abduction torque (Nm/kg) 0.9 (0.3) 0.8 (0.3) 1.0 (0.3)
Hip adduction torque (Nm/kg) 0.8 (0.3) 0.8 (0.3) 0.9 (0.3)
Hip extension torque (Nm/kg) 1.9 (0.6) 1.8 (0.6) 2.1 (0.7)
Hip internal rotation torque (Nm/kg) 0.4 (0.2) 0.4 (0.2) 0.5 (0.2)
Hip external rotation torque (Nm/kg) 0.4 (0.1) 0.4 (0.2) 0.4 (0.1)
y Values were adjusted for the baseline value of the variable.occurred in six participants in the exercise group, three of these
during follow-up testing (participants inadvertently mentioning
exercises), and three immediately after follow-up data collection
(participants questioned whether to continue exercises).
Knee loading and biomechanics
Table II demonstrates no difference between strengthening and
control groups for change in the external knee adduction moment
[0.148 (95% conﬁdence interval (CI) 0.039 to 0.335) Nm/BWHT
%]. In fact, rather than reduced knee load as hypothesised, the
strengthening group showed a tendency towards (4.6% adjusted)
increased knee adduction moment over the 12 weeks [compared
with 0.5% adjusted increase in control participants (P¼ 0.19)].
Results were unchanged when change in walking pain during gait
analysis was removed as a covariate (P¼ 0.12) or when only indi-
viduals who completed the study were analysed (P¼ 0.11).
There were no between-group differences in change of peak
external hip adduction moment, knee adduction impulse, or
maximum ipsilateral trunk lean. Signiﬁcant between-group group
differences were noted for change in maximum contralateral pelvic
drop [0.765 (95% CI 0.152e1.379)] whereby the strengthening
group showed a 15% increase and the controls a 7% decrease
(P¼ 0.015).
Pain and function
All measures of pain and physical function showed signiﬁcantly
greater improvements in the strengthening group compared with
the control group (all P< 0.05) (Table III). Improved pain and
physical function was reported by 31/39 (80%) participants in thebetween groups for pain, physical function and strength
Difference within groups,
adjusted mean (SE)y
Difference between groups,
adjusted mean (95% CI)y
Week 13eWeek 0 Week 13eWeek 0
ontrol Exercise Control ExerciseeControl P-values
3.9 (2.6) 1.61 (0.28) 0.24 (0.28) 1.37 (2.16, 0.59) 0.0008
1.9 (11.0) 8.07 (1.15) 1.90 (1.16) 6.17 (9.41, 2.93) 0.0003
6.5 (3.3) 2.60 (0.39) 0.48 (0.40) 2.12 (3.24, 1.00) 0.0003
6.9 (2.8) 1.76 (0.32) 0.80 (0.32) 0.96 (0.07, 1.86) 0.0358
7.9 (1.8) 0.97 (0.19) 0.25 (0.19) 0.73 (1.25, 0.20) 0.0072
1.4 (0.5) 0.16 (0.03) 0.05 (0.03) 0.11 (0.02, 0.21) 0.0152
0.7 (0.2) 0.07 (0.03) 0.01 (0.03) 0.08 (0.01, 0.16) 0.0325
0.9 (0.3) 0.14 (0.03) 0.03 (0.03) 0.11 (0.04, 0.19) 0.0022
0.8 (0.3) 0.15 (0.02) 0.024 (0.023) 0.13 (0.06, 0.19) 0.0002
1.9 (0.6) 0.19 (0.04) 0.04 (0.04) 0.15 (0.04, 0.27) 0.0115
0.4 (0.2) 0.04 (0.02) 0.01 (0.02) 0.05 (0.01, 0.10) 0.0269
0.4 (0.2) 0.04 (0.01) 0.02 (0.01) 0.05 (0.02, 0.09) 0.0048
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(P< 0.0001). The relative risk (95% CI) of improvement in the
strengthening group compared to the control group was 20.02
(6.21e64.47).
Strength
Changes in hip strength were signiﬁcantly different between
groups (Table III). In particular, the hip abductor and adductor
strength increased by 13% and 19%, respectively, in the strength-
ening group, compared with 4% and 3%, respectively, in the control
group. The strengthening group also showed a signiﬁcantly greater
increase in knee extension strength compared to controls (11% vs
3% P¼ 0.015).
Adherence, co-interventions and adverse effects
For the strengthening group, the mean (SD) physiotherapy
attendance rate and home exercise compliance rate were 96% (11%)
and 89% (7%), respectively. Five participants reported an adverse
event: three reported back pain, one reported back and hip pain,
and one reported aggravated varicose veins and knee pain for
which acupuncture treatment was sought. Only one participant in
the strengthening group (in addition to the one requiring
acupuncture noted above) sought a co-intervention (ultrasound
and strapping from a physiotherapist). In the control group, seven
participants sought treatment including knee arthroscopy (n¼ 1),
physiotherapy and massage (n¼ 1), osteopathy (n¼ 1), trigger
point needling and non-steroidal anti-inﬂammatory gel (n¼ 1),
massage (n¼ 1), and topical creams (n¼ 2). Eighteen exercise
participants and 14 controls reported increased medication use,
whilst 15 and nine, respectively reported decreased medication use
at any point in the trial.
Discussion
This study showed that hip strengthening had no signiﬁcant
effect on the external knee adduction moment, an indicator of
medial tibiofemoral compartment load during walking and
a biomechanical factor linked to disease progression, in people with
medial tibiofemoral OA and varus malalignment. Despite no effect
on the knee adduction moment, the hip strengthening program did
lead to signiﬁcant improvements in pain and physical function.
This is the ﬁrst randomised controlled trial to investigate the
speciﬁc effects of hip muscle strengthening in knee OA. Our
research extends the work of others in this area. An 18-month
longitudinal observational study indicated that a lower external hip
adduction moment (internal hip abduction moment) was associ-
ated with an increased risk of medial knee OA structural progres-
sion23. To explain their ﬁndings, Chang et al.23 proposed that
weaker hip abductors e assumed to be associated with a lower
external hip adduction moment e on the osteoarthritic stance limb
would result in additional pelvic drop of the contralateral swing
limb, shifting the body's centre of mass towards the swing limb.
This would lengthen the lever arm at the osteoarthritic knee, thus
increasing medial knee load and hastening disease progression.
This hypothesis is supported by a cross-sectional study that showed
that those with more severe knee OA had lower external hip
adduction moments and higher knee adduction moments than
those with less severe disease22. However, although our exercise
program achieved a 13% increase in hip abductor strength, we
observed no change in the external hip adduction moment,
a signiﬁcant increase in contralateral pelvic drop, and no change in
the external knee adduction moment.Although it is often presumed that the external hip adduction
moment reﬂects hip abductor strength, this is not necessarily the
case as the relationship is more complex. This moment, measured
by inverse dynamics, is a net moment and cannot be attributed to
any single muscle group; rather it represents the overall effect of
all moment-generators (both active and passive structures) in both
abduction and adduction directions. Furthermore, the moment
will be inﬂuenced by movement characteristics, particularly at the
pelvis and trunk, as these will determine the extent to which hip
muscles are required to be activated. As such, there may not
necessarily be a close relationship between hip abductor strength
and the hip adduction moment as demonstrated recently in
a study of healthy individuals42. Furthermore, Henriksen et al.43
found that a reduction in the external hip adduction moment
associated with experimental pain-induced hip abductor weakness
in healthy individuals led to a reduction, rather than an increase, in
the knee adduction moment. This further challenges the premise
that hip muscle strengthening would lead to a reduction in the
knee adduction moment. Taken together with our results, these
disparate ﬁndings highlight the complexity of the relationship
between hip muscle strength, muscle activation levels, hip and
pelvic movement patterns, hip moments and ultimately medial
knee load.
It might be argued that our failure to demonstrate changed
external hip and knee adduction moments was because our cohort
did not exhibit substantial hip muscle weakness in the ﬁrst place.
However, comparison of our cohort with an age-matched asymp-
tomatic control group (n¼ 24) revealed adjusted average strength
deﬁcits in the order of 23% for the hip abductors and 25% for the hip
adductors49. Instead, it may be that our patients altered their gait
mechanics following hip strengthening in such a manner that
counteracted any potential beneﬁts for knee loading. For example,
the exercise group exhibited a small but signiﬁcant decrease in
lateral trunk lean (likely associatedwith the increase in pelvic drop)
with the hip strengthening program, consistentwith improvements
in hip abductor strength and reductions in pain. Reduced trunk lean
is known to increase the knee adduction moment24,25. Thus, it is
possible that any direct effects of improved hip strength on the knee
adduction moment may have been cancelled out by reductions in
compensatory lateral trunk lean. It is also possible that our partici-
pants did not use their increased hip muscle strength, despite the
overall strength increases we observed. Although our training
program provided participants with greater potential to advanta-
geously use hip muscle strength, it did not speciﬁcally teach
participants how to use their enhanced strength functionally.
Perhaps a motor control program incorporating eccentric hip
abductor training in single leg stance and co-ordination during
functional activities have been more speciﬁc to achieving a reduc-
tion in the external knee adduction moment.
Relative to hip abductor function, less is known about the hip
adductor muscles in knee OA. By virtue of their attachment to the
distal medial femoral condyle, the adductors could eccentrically
restrain the tendency of the femur to move further into varus thus
reducing the knee adduction moment. Yamada et al.26 found that
patients with knee OA had stronger hip adductors compared with
age-matched controls, and that those with more severe OA had
even stronger adductors than their less severe counterparts. They
hypothesised that this increased strength may be due to greater
eccentric use of the hip adductors to control femoral varus and
lower the knee adduction moment. We anticipated that addition of
hip adductor strengthening would complement the proposed
beneﬁts of improved hip abductor strength on medial knee load.
However, our results do not lend support to a beneﬁcial effect of
a combined program including hip adductor strengthening on the
knee adduction moment.
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were found in the hip strengthening group. It is possible that some
symptomatic beneﬁt of strengthening may be attributed to indirect
(placebo) treatment effects related to the therapeutic environment
and/or expectationof beneﬁt44. Given that our control group received
no treatment rather than placebo treatment, this cannot be ascer-
tained. However, given that placebo effects are typically conﬁned to
painandother self-reportmeasures45, our improvements inobjective
measures of physical function are unlikely to be due simply to
a placebo effect but rather to the direct effects of the exercises.
The clinical improvements noted are consistent with the results
of numerous studies demonstrating a beneﬁcial effect of
strengthening on pain and function in knee OA16. While our exer-
cises speciﬁcally targeted the hip musculature, the quadriceps also
improved in strength given their need to maintain knee extension
duringmany of the hip exercises. Asmuscle strength, particularly of
the quadriceps, is an important predictor of both pain and physical
function46,47, it is not surprising that improvements in muscle
strength translated into symptomatic improvement. Regardless of
the mechanism of effect, our results indicate that a hip strength-
ening program can provide symptomatic beneﬁts for patients with
knee OA. This may be particularly useful for patients in whom
quadriceps exercises are too painful.
The strengths of our study include the rigorous study design,
speciﬁc recruitment of patients with varus malalignment, excellent
participant retention and adherence, and successful strengthening of
the target muscle groups. A limitation is that the participants and
therapists were not blinded to the intervention, which is difﬁcult in
a trial of this nature. However, this is unlikely to have biased the
primary outcome given the use of an objective measurement of the
knee adductionmoment. As acknowledged, the lack of an intervention
for the control group may have inﬂuenced the outcomes for the
secondary self-reportmeasures of pain and function. Furthermore, we
did not directly assess structural disease progression. Rather, we used
the commonly accepted surrogate measure of medial compartment
loade the external knee adductionmomentwhichhas been related to
disease progression6. However, it is conceivable that participants
experienced changes in medial compartment loading that were not
reﬂected inchanges in theexternal adductionmoment. Thus,whileour
results do not support hip strengthening as an OA disease-modifying
intervention, thiswouldneed tobe conﬁrmedusingdirectmeasures of
structural change such as magnetic resonance imaging. Another issue
worthy of further consideration is whether speciﬁc patient character-
istics predict a better response to hip strengthening treatment as this
may highlight patient subgroups in whom the treatment might be
most effective for improving symptoms48.
In summary, our data do not support hip muscle strengthening
as a potentially disease-modifying intervention in medial knee OA.
We found that strengthening the hip abductor and adductor
muscles improved symptoms in this patient group, but did not
affect medial knee load as measured by the knee adduction
moment. Hence the mechanism by which a higher hip adduction
moment is protective against disease progression23 is unclear.
Further work is warranted to investigate if other conservative
interventions can increase the hip adduction moment, reduce
medial knee load and slow structural disease progression.
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